Cresset Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CPRX
GCL
HI
Cresset Asset Management's CPRX Position: Q2 2026 in Review
Cresset Asset Management increased its Catalyst Pharmaceutical (CPRX) stake by 26% in Q2 2026, buying an estimated $661K and bringing the position to 108,452 shares worth $3.41M. The position accounts for 0.01% of the portfolio, ranked #507.
Cresset Asset Management first reported a position in CPRX in Q1 2025 and has held it in 6 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.
- Cresset Asset Management held 108,452 shares of Catalyst Pharmaceutical worth $3.41M as of Q2 2026.
- Cresset Asset Management bought 22,389 Catalyst Pharmaceutical shares in Q2 2026, an estimated $661K.
- Catalyst Pharmaceutical made up 0.01% of Cresset Asset Management's portfolio in Q2 2026, its #507 holding.
- Cresset Asset Management first reported a position in Catalyst Pharmaceutical in Q1 2025 and has held it in 6 quarters since.
- 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.
Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.